Detection efficacy of [89Zr]Zr-PSMA-617 PET/CT in [68Ga]Ga-PSMA-11 PET/CT-negative biochemical recurrence of prostate cancer

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource, 1 online resource.

Language: Englisch

Bibliographic citation: Detection efficacy of [89Zr]Zr-PSMA-617 PET/CT in [68Ga]Ga-PSMA-11 PET/CT-negative biochemical recurrence of prostate cancer ; volume:50 ; number:9 ; day:6 ; month:5 ; year:2023 ; pages:2899-2909 ; date:7.2023
European journal of nuclear medicine and molecular imaging ; 50, Heft 9 (6.5.2023), 2899-2909, 7.2023

Creator: Rosar, Florian
Khreish, Fadi
Marlowe, Robert J.
Schaefer-Schuler, Andrea
Burgard, Caroline
Maus, Stephan
Petto, Sven
Bartholomä, Mark
Ezziddin, Samer

Contributor: SpringerLink (Online service)

DOI: 10.1007/s00259-023-06241-0

URN: urn:nbn:de:101:1-2023093011345452009620

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:02 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Rosar, Florian
Khreish, Fadi
Marlowe, Robert J.
Schaefer-Schuler, Andrea
Burgard, Caroline
Maus, Stephan
Petto, Sven
Bartholomä, Mark
Ezziddin, Samer
SpringerLink (Online service)

Other Objects (12)

Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer

68Ga-PSMA PET-CT Imaging of Metastatic Adenoid Cystic Carcinoma

Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer

Comparison of 68Ga-PSMA PET/CT with fluoride PET/CT for detection of bone metastatic disease in prostate cancer

68Ga-PSMA-11 PET/CT mit low-dose CT : Diagnostischer Zugewinn durch minimale kontrastmittelgestützte Urographie

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]

Stellenwert der 68Ga-PSMA-11 PET/CT bei Patienten mit bioptisch gesichertem Prostatakarzinom

68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy

Hybrid imaging with [68Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer

Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy

Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer

68Ga-PSMA PET-CT Imaging of Metastatic Adenoid Cystic Carcinoma

Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer

Comparison of 68Ga-PSMA PET/CT with fluoride PET/CT for detection of bone metastatic disease in prostate cancer

68Ga-PSMA-11 PET/CT mit low-dose CT : Diagnostischer Zugewinn durch minimale kontrastmittelgestützte Urographie

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]

Stellenwert der 68Ga-PSMA-11 PET/CT bei Patienten mit bioptisch gesichertem Prostatakarzinom

68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy

Hybrid imaging with [68Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer

Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy

Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer

68Ga-PSMA PET-CT Imaging of Metastatic Adenoid Cystic Carcinoma

Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer

Comparison of 68Ga-PSMA PET/CT with fluoride PET/CT for detection of bone metastatic disease in prostate cancer

68Ga-PSMA-11 PET/CT mit low-dose CT : Diagnostischer Zugewinn durch minimale kontrastmittelgestützte Urographie

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]

Stellenwert der 68Ga-PSMA-11 PET/CT bei Patienten mit bioptisch gesichertem Prostatakarzinom

68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy

Hybrid imaging with [68Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer

Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Detection efficacy of [89Zr]Zr-PSMA-617 PET/CT in [68Ga]Ga-PSMA-11 PET/CT-negative biochemical recurrence of prostate cancer

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer

68Ga-PSMA PET-CT Imaging of Metastatic Adenoid Cystic Carcinoma

Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer

Comparison of 68Ga-PSMA PET/CT with fluoride PET/CT for detection of bone metastatic disease in prostate cancer

68Ga-PSMA-11 PET/CT mit low-dose CT : Diagnostischer Zugewinn durch minimale kontrastmittelgestützte Urographie

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]

Stellenwert der 68Ga-PSMA-11 PET/CT bei Patienten mit bioptisch gesichertem Prostatakarzinom

68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy

Hybrid imaging with [68Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer

Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy

Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy

Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer

68Ga-PSMA PET-CT Imaging of Metastatic Adenoid Cystic Carcinoma

Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer

Comparison of 68Ga-PSMA PET/CT with fluoride PET/CT for detection of bone metastatic disease in prostate cancer

68Ga-PSMA-11 PET/CT mit low-dose CT : Diagnostischer Zugewinn durch minimale kontrastmittelgestützte Urographie

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]

Stellenwert der 68Ga-PSMA-11 PET/CT bei Patienten mit bioptisch gesichertem Prostatakarzinom

68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy

Hybrid imaging with [68Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer

Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy

Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy

Meta-analysis of 18 F-PSMA-1007 PET/CT, 18 F-FDG PET/CT, and 68Ga-PSMA PET/CT in diagnostic efficacy of prostate Cancer

68Ga-PSMA PET-CT Imaging of Metastatic Adenoid Cystic Carcinoma

Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer

Comparison of 68Ga-PSMA PET/CT with fluoride PET/CT for detection of bone metastatic disease in prostate cancer

68Ga-PSMA-11 PET/CT mit low-dose CT : Diagnostischer Zugewinn durch minimale kontrastmittelgestützte Urographie

68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]

Stellenwert der 68Ga-PSMA-11 PET/CT bei Patienten mit bioptisch gesichertem Prostatakarzinom

68Ga-PSMA PET/CT in early relapsed prostate cancer patients after radical therapy

Hybrid imaging with [68Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer

Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy

Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy

Related objects

Reset password